Back to Business

Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Transcript

Business October 8, 2026 at 12:12 AM

Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Transcript

Seeking Alpha

Read the full story at Seeking Alpha

More Stories

Walker & Dunlop, Inc. (WD) Discusses Real Estate Capital Markets Volatility and Interest Rate Outlook Transcript

Walker & Dunlop, Inc. (WD) Discusses Real Estate Capital Markets Volatility and Interest Rate Outloo…

🇺🇸 Seeking Alpha 31m ago

Bezos says Blue Origin likely to pursue IPO in coming years

Bezos says Blue Origin likely to pursue IPO in coming years

🇺🇸 Investing.com 35m ago

BillionToOne CTO David Tsao sells $2.16m in shares

BillionToOne CTO David Tsao sells $2.16m in shares

🇺🇸 Investing.com 37m ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play